International audienceMycobacterium leprae, the causative agent of leprosy, is unique amongst human pathogens in its capacity to produce the virulence factor phenolic glycolipid (PGL)-I. In addition to mediating bacterial tropism for neurons, PGL-I interacts with Complement Receptor (CR)3 on macrophages (MPs) to promote infection. We demonstrate here that PGL-I binding to CR3 also enhances bacterial invasion of both polymorphonuclear neutrophils (PMNs) and dendritic cells (DCs). Moreover, in all cell types CR3 engagement by PGL-I activates the Syk tyrosine kinase, inducing calcineurin-dependent nuclear translocation of the transcription factor NFATc. This selectively augments the production of IL-2 by DCs, IL-10 by PMNs and IL-1β by MPs. In...
Session : Vaccins, Immunothérapie, Immunoprophylaxie adjuvantsNational audienceIntroduction : Parmi ...
Session : Vaccins, Immunothérapie, Immunoprophylaxie adjuvantsNational audienceIntroduction : Parmi ...
Session : Vaccins, Immunothérapie, Immunoprophylaxie adjuvantsNational audienceIntroduction : Parmi ...
International audienceMycobacterium leprae, the causative agent of leprosy, is unique amongst human ...
International audienceMycobacterium leprae, the causative agent of leprosy, is unique amongst human ...
Mycobacterium leprae, the causative agent of leprosy, is unique amongst human pathogens in its capac...
Mycobacterium leprae; , the causative agent of leprosy, is unique amongst human pathogens in its cap...
The species-specific phenolic glycolipid 1 (PGL-1) is suspected to play a critical role in the patho...
International audienceThe species-specific phenolic glycolipid 1 (PGL-1) is suspected to play a crit...
Lepromatous leprosy is a model of immune evasion wherein pathogen-specific IL-10-secreting T cells a...
Mycobacterium leprae, an obligate intracellular bacillus, infects Schwann cells (SCs), leading to pe...
We have examined phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages (MDM). C...
We have examined phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages (MDM). C...
<p>(1) Pathogen or damage-associated molecular sugar patterns (PAMPs/DAMPs) on <i>Mycobacterium lepr...
We have examined phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages (MDM). C...
Session : Vaccins, Immunothérapie, Immunoprophylaxie adjuvantsNational audienceIntroduction : Parmi ...
Session : Vaccins, Immunothérapie, Immunoprophylaxie adjuvantsNational audienceIntroduction : Parmi ...
Session : Vaccins, Immunothérapie, Immunoprophylaxie adjuvantsNational audienceIntroduction : Parmi ...
International audienceMycobacterium leprae, the causative agent of leprosy, is unique amongst human ...
International audienceMycobacterium leprae, the causative agent of leprosy, is unique amongst human ...
Mycobacterium leprae, the causative agent of leprosy, is unique amongst human pathogens in its capac...
Mycobacterium leprae; , the causative agent of leprosy, is unique amongst human pathogens in its cap...
The species-specific phenolic glycolipid 1 (PGL-1) is suspected to play a critical role in the patho...
International audienceThe species-specific phenolic glycolipid 1 (PGL-1) is suspected to play a crit...
Lepromatous leprosy is a model of immune evasion wherein pathogen-specific IL-10-secreting T cells a...
Mycobacterium leprae, an obligate intracellular bacillus, infects Schwann cells (SCs), leading to pe...
We have examined phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages (MDM). C...
We have examined phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages (MDM). C...
<p>(1) Pathogen or damage-associated molecular sugar patterns (PAMPs/DAMPs) on <i>Mycobacterium lepr...
We have examined phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages (MDM). C...
Session : Vaccins, Immunothérapie, Immunoprophylaxie adjuvantsNational audienceIntroduction : Parmi ...
Session : Vaccins, Immunothérapie, Immunoprophylaxie adjuvantsNational audienceIntroduction : Parmi ...
Session : Vaccins, Immunothérapie, Immunoprophylaxie adjuvantsNational audienceIntroduction : Parmi ...